Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Activated oncogenes and anticancer chemotherapy induce cellular senescence, a terminal growth arrest of viable cells characterized by S-phase entry-blocking histone 3 lysine 9 trimethylation (H3K9me3). Although therapy-induced senescence (TIS) improves long-term outcomes, potentially harmful properties of senescent tumour cells make their quantitative elimination a therapeutic priority. Here we use the Eµ-myc transgenic mouse lymphoma model in which TIS depends on the H3K9 histone methyltransferase Suv39h1 to show the mechanism and therapeutic exploitation of senescence-related metabolic reprogramming in vitro and in vivo. After senescence-inducing chemotherapy, TIS-competent lymphomas but not TIS-incompetent Suv39h1(-) lymphomas show increased glucose utilization and much higher ATP production. We demonstrate that this is linked to massive proteotoxic stress, which is a consequence of the senescence-associated secretory phenotype (SASP) described previously. SASP-producing TIS cells exhibited endoplasmic reticulum stress, an unfolded protein response (UPR), and increased ubiquitination, thereby targeting toxic proteins for autophagy in an acutely energy-consuming fashion. Accordingly, TIS lymphomas, unlike senescence models that lack a strong SASP response, were more sensitive to blocking glucose utilization or autophagy, which led to their selective elimination through caspase-12- and caspase-3-mediated endoplasmic-reticulum-related apoptosis. Consequently, pharmacological…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another approach is based on the high lysosomal activity of some senescent cells that renders them sensitive to lysosomal ATPase inhibitors94.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [94]
In the citing paper
“In preclinical models, proteotoxic stress not only drives entry into a senescent state, but also activates autophagy, which consequently buffers toxicity from misfolded SASP factors 44,45 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“These findings suggest that mTOR inhibitors, commonly referred to as rapalogs, might induce or prevent senescence in a context- dependent manner 45,48,49 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“Multiple factors involved in senescence induction, such as oxidative stress and proteotoxic stress, lead to protein misfolding, which in turn evokes endoplasmic reticulum stress via the unfolded protein response 45,53 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
In the citing paper
“Reconversion of lactate to pyruvate by l-lactate dehydrogenase B fuels the TCA cycle out of the senescence-enforced enhancement of non-oxidative glucose metabolism (commonly referred to as the Warburg effect) 45 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [45]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Gas chromatography mass spectrometry–based metabolite profiling in plants
Lisec, J., Schauer, N., Kopka, J., Willmitzer, L., & Fernie, A. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.59 · Cited by 2,170
Self-citation
Cited by
Items 401–500 of 540
Implications of cellular senescence in paediatric pituitary tumours
González-Meljem, J. M., & Martínez-Barberá, J. P. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104905 · Cited by 9
Targeting the stress support network regulated by autophagy and senescence for cancer treatment
Kim, J., Lee, Y., Roh, K., Kim, M.-S., & Kang, C. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.003 · Cited by 7
Zhang, Y., Qian, S., Wen, Q., Lei, Y., Ge, J., Kong, X., Wang, W., Wang, Z., Hou, H., Tang, C., et al. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03128-2 · Cited by 8
“TIScompetent lymphomas, which are SUV39H1 (+) lymphomas, can increase glucose utilization, produce more ATP and prompt tumor regression [31].”
BackgroundNoguchi, F., Inui, S., Fedele, C. G., Shackleton, M. J., & Itami, S. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0235 · Cited by 8
“S6H and S6I), consistent with a hyperactive hybrid metabolism, characterized by increased glycolysis as well as mitochondrial respiration, that is linked to the senescent state (12, 13).”
BackgroundLenin, R. R., Nagy, P. G., Gentry, J., & Gangaraju, R. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218794915 · Cited by 7
Tachikart, Y., Malaise, O., Constantinides, M., Jørgensen, C., & Brondello, J. (2018) · médecine/sciences · doi:10.1051/medsci/20183406014 · Cited by 9
Expansion of senescent megakaryocyte-lineage cells maintains CML cell leukemogenesis
Tanabe, Y., Kawamoto, S., Takaku, T., Morishita, S., Hirao, A., Komatsu, N., Hara, E., Mukaida, N., & Baba, T. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003117 · Cited by 10
“In the Em-myc transgenic mouse lymphoma model, autophagy is essential for the maintenance of cell viability under chemotherapy-induced senescence.(38) Moreover, autophagy is activated during oncogenic Ras-induced OIS.”
BackgroundAutophagy in cancer biology and therapy
Gammoh, N., & Wilkinson, S. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1294-2 · Cited by 10
“…study it was shown that upon treatment of transplanted mouse lymphomas driven by an overexpressed MYC proto-oncogene, where additional genetic aberrations have disabled the apoptotic machinery, chemotherapeutic agents do not clear cancer cells but instead induce senescence (Dörr et al., 2013).”
Fukushima, Y., Naito, T., Sueyoshi, K., Kubo, T., Kitagawa, F., & Otsuka, K. (2014) · Analytical Chemistry · doi:10.1021/ac501039j · Cited by 7
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · Inside the Cell · doi:10.1002/icl3.1046 · Cited by 11
Moore, M. H., Gammon, L., Dreger, S. A., Koh, J., Garbe, J. C., Stampfer, M. R., Philpott, M. P., Jones, L., & Bishop, C. L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/469445 · Cited by 6
Zhang, Y., Chu, J., Hou, Q., Qian, S., Wang, Z., Yang, Q., Song, W., Dong, L., Shi, Z., Gao, Y., et al. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5653 · Cited by 7
“Lymphoma stem‑like cells (CD34 + and CD44 + ) with high ABCG2 expres‑ sion exhibited a senescent phenotype in mouse models (37).”
BackgroundCollateral lethality: A unique type of synthetic lethality in cancers
Zhao, Z., Zhu, L., Luo, Y., Xu, H., & Zhang, Y. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108755 · Cited by 6
Zhang, J., Yang, J., Xu, C., Hu, Q. Z., Hu, J. X., Chen, J., & Jiang, H. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14809 · Cited by 6
Nutritional Modulators of Cellular Senescence In Vitro
Provinciali, M., Pierpaoli, E., Piacenza, F., Giacconi, R., Costarelli, L., Basso, A., Recchioni, R., Marcheselli, F., Bray, D. H., Benlhassan, K., et al. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00022-4 · Cited by 8
CUL4B Promotes Temozolomide Resistance in Gliomas by Epigenetically Repressing CDNK1A Transcription
Ye, X., Liu, X., Gao, M., Gong, L., Tian, F., Shen, Y., Hu, H., Sun, G., Zou, Y., & Gong, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638802 · Cited by 7
“Growing evidence shows that therapy-induced senescence in tumors is associated with improved clinical outcomes (19–21), and inducing senescence in cancers has recently been explored as a therapeutic strategy with the potential to reduce cytotoxicity (22, 23), and potentiate drug combinations (24).”
BackgroundXie, Y., Luo, X., Di, X., Li, J., Xia, Y., Wang, L., & Liu, Y. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02543 · Cited by 5
Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis
Yang, S., Lin, M., Hao, S., Ye, H., & Zhang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1497461 · Cited by 5
Giroud, J., Delvaux, P., Carlier, L., de Schutter, C., Martin, N., Rouget, R., Bolouki, A., Glas, V. D., Bouriez, I., Bourdoux, F., et al. (2025) · Aging Cell · doi:10.1111/acel.70024 · Cited by 7
“Interestingly, there is evidence that different cell types, when undergoing senescence, display UPR activation (Denoyelle et al. 2006; Dörr et al. 2013; Blazanin et al. 2017; Kim et al. 2019; Sabath et al. 2020).”
In vitro senescence and senolytic functional assays
Ryan, P., & Lee, J. (2025) · Biomaterials Science · doi:10.1039/d4bm01684j · Cited by 7
Quantitative Analysis of Cancer Metabolism: From pSIRM to MFA
Zasada, C., & Kempa, S. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_9 · Cited by 6
Self-citationUncovering cellular senescence as a therapeutic target in NF2-related vestibular schwannoma
Franco-Caspueñas, S., García‐Montoya, C., Contreras, J., Lassaletta, L., Varela‐Nieto, I., & Jimenez-Lara, A. M. (2024) · Hearing Research · doi:10.1016/j.heares.2024.109165 · Cited by 5
“…attenuates the detrimental local and systemic effects exerted by senescent cells that would otherwise remain in aged, diseased or damaged tissues (Chang et al., 2016; Dörr et al., 2013; Kirkland and Tchkonia, 2020; Paez‐Ribes et al., 2019; Saleh et al., 2020; Xu et al., 2018; Zhu et al., 2015).”
Kaliaperumal, J., Padarthi, P., Elangovan, N., & Hari, N. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.07.016 · Cited by 5
ATF4, Hypoxia and Treatment Resistance in Cancer
Singleton, D. C., & Harris, A. L. (2019) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-05067-2_4 · Cited by 7
Multiple characteristic alterations and available therapeutic strategies of cellular senescence
Zhao, Y., Li, H., Guo, Q., & Hui, H. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200178 · Cited by 5
[Synthetic lethal genes to mutant p53].
Liu, T.-Y., Guo, H.-Q., Zhu, M., Huang, Y., Jia, S., Luo, Y., & Zhang, J. (2015) · PubMed · doi:10.16288/j.yczz.14-277 · Cited by 5
“[1] Dörr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Däbritz JH, Lisec J, Lenze D, Gerhardt A, Schleicher K, Kratzat S, Pürfurst B, Walenta S, Mueller-Klieser W, Gräler M, Hummel M, Keller U, Buck AK, Dörken B, Willmitzer L, Reimann M, Kempa S, Lee S, Schmitt CA.”
BackgroundIsakova, A. A., Mazur, D. V., Антипова, Н. В., Николаевна, Д. И., Mozherov, A. M., Krasnov, K. S., Фадеев, Р. С., Kirpichnikov, M. P., Gasparian, M. E., & Yagolovich, A. V. (2025) · Medical Oncology · doi:10.1007/s12032-025-03130-4 · Cited by 5
Giroud, J., Combémorel, E., Pourtier, A., Abbadie, C., & Pluquet, O. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00091.2025 · Cited by 10
Directly Evolved Nanovaccines Modulate Disrupted Circadian Rhythm and Enhance Cancer Immunotherapy
Han, Z., Zhang, C., An, J., Wang, Y., Zeng, X., & Zhang, X. (2025) · Advanced Materials · doi:10.1002/adma.202502602 · Cited by 8
Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging
Fang, H., Yu, E., Liu, C., Eapen, C., Cheng, C., & Hu, T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.003 · Cited by 5
You, R., Wang, L., Liu, L., Wang, Y., Han, K., Lin, H., Wang, Y., Raftery, D., & Guan, Y. (2021) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3174 · Cited by 4
Xu, D., Chen, X., Wu, M., Bi, J., Xue, H., & Chen, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28278 · Cited by 6
Autophagy-Driven Cancer Drug Development
Belaïd, A., Roméo, B., Filippakis, H., Meyer, M., Grosjean, I., Yazbeck, N., Domdom, M. A., Crépeaux, G., Gherardi, R. K., Lagadic‐Gossmann, D., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00021-3 · Cited by 4
Targeting proteostasis maintenance and autophagy in senescence
L’Hôte, V., Mann, C., & Thuret, J. (2022) · Aging · doi:10.18632/aging.203941 · Cited by 4
Yang, S., Shen, T., Yu, M., Wu, T., Qian, L., Liu, W., Wang, T., & Huang, X. (2025) · Communications Biology · doi:10.1038/s42003-025-08296-1 · Cited by 8
“In addition to the telomere shortening discovered by Hay fl ick and Moorhead in 1961 12 , various stress stimuli like oncogenic 13 , oxidative 14 , lysosomal/endoplasmic reticulum stress 15,16 , and nutrient depletion 17 can trigger senescence.”
Natural killer cell-based senotherapy: a promising strategy for healthy aging
中澤務, Yamanishi, R., Morimoto, T., & Matusda, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1737572 · Cited by 4
“Although SNCs lose their proliferative potential, they remain metabolically active (55) and may preserve certain functional properties of their progenitors.”
Zhao, Y. (2026) · Biogerontology · doi:10.1007/s10522-026-10410-7 · Cited by 3
“…vulnerabilities of senescent cells, for example, using their high dependence on autophagy and lysosomal function to design selective lysosomal inhibitors, or implementing metabolic restriction-induced killing targeting their sensitivity to glucose or glutamine deprivation (Dörr et al. 2013).”
The Rise of Trapped Ion Mobility Spectrometry: Principles, Applications, and Recent Developments
Panczyk, E. M., Martelli, C., Ridgeway, M. E., Ekelöf, M., Hornburg, D., Jones, B. J., Wootton, C. A., Lewis, M. R., Pengelley, S., Greisch, J., et al. (2026) · Mass Spectrometry Reviews · doi:10.1002/mas.70034 · Cited by 3
Senescent cells: a therapeutic target in correction of aging
Kirichenko, T. V., Markina, Y. V., Markin, A. M., Eremin, I. I., & Deev, R. V. (2024) · Восстановительные биотехнологии, профилактическая, цифровая и предиктивная медицина. · doi:10.17116/rbpdpm2024103153 · Cited by 5
Liu, J., Li, H., Sun, R., Ying, G., & Liang, Z. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03818-7 · Cited by 4
Metabolism under the spotlight in senescence
Bertolotto, C. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12184 · Cited by 3
“Interestingly, although most cancer cells have conceivably bypassed OIS, several reports indicate that they are still able to enter senescence in response to chemotherapy drugs, a process called therapy-induced senescence (TIS) (Ohanna et al 2011, Schmitt et al 2002).”
BackgroundThe silent guardian: unraveling the roles of H3K9me3 in genome maintenance
Li, Z., & Zhang, Z. (2024) · Genome Instability & Disease · doi:10.1007/s42764-024-00131-x · Cited by 3
“…H3K9me3 also drives the long-term effects of stress response, such as therapy-or oncogene-induced senescence that alters tumor progression and treatment outcomes (Braig et al., 2005; Di Micco et al., 2011; Dorr et al., 2013; Milanovic et al., 2018; Schleich et al., 2020; Yu et al., 2018b).”
Jacobs, L., Habringer, S., Slawska, J., Huber, K., Hauf, E., Li, Z., Refaeli, Y., Schwaiger, M., Rudelius, M., Walch, A. K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20551 · Cited by 3
“Despite established imaging methods such as 18F-FDG-PET facilitating assessment of therapy response and prediction of disease-free survival [15, 16], emerging molecular imaging methods such as matrix-assisted laser desorption ionization imaging mass spectrometry (MALDI IMS) are now able to identify proteins, metabolit…”
MethodSelf-citationCellular Senescence and Tumor Promotion
Demaria, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_79 · Cited by 4
Qi, J., Lin, J., Wu, C., He, H., Yao, J., Xu, Y., Yang, Y., Wei, Y.-F., Huang, D., & Mao, Y. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/5343746 · Cited by 3
“The results of KEGG also suggested that the oncogenesis-related gene set might involve cellular senescence, transcriptional misregulation in cancer, HIF-1 signaling pathway, and FoxO signaling pathway, which have been revealed by previous studies to be involved in the tumorigenesis of AML [29 – 32].”
How to Personalize Chemotherapy in Stage IV NSCLC?
Karachaliou, N., Rosell, R., & Carcereny, E. (2014) · Springer eBooks · doi:10.1007/978-3-319-06062-0_8 · Cited by 3
“For instance, they may be capable of cell cycle reentry, affect stemness, secrete paracrine-active factors, and promote infl ammation [ 35 ].”
BackgroundInfluentialc-Myc: Central regulator of autophagy and senescence in cancer
Ji, S., Sun, T., Zhang, Q., Wu, M., Cao, Y., Gao, R., Wang, L., Nicot, C., & Sethi, G. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218315 · Cited by 4
Singh, D., & Bhattacharya, S. (2026) · Therapeutic Delivery · doi:10.1080/20415990.2026.2668850 · Cited by 3
Molecular mechanisms and recent advances in cellular senescence
Hussain, A., Tatar, M., & Gong, R. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01596-x · Cited by 4
“Studies with role of biologically relevant small molecules in senescence have confirmed that like normal cells, transformed cells also enter into a senescent state and there are no separate biological markers of senescence in normal and cancer cells [48, 49].”
Pro-senescence Therapy for Cancer: Time for the Clinic
Kalathur, M., Mitri, D. D., & Alimonti, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_8 · Cited by 2
Open Access to High-Content Clonogenic Analysis
Ricci, F., Subramanian, A., & Wade, M. R. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114557775 · Cited by 2
“By setting a threshold in the untreated population, we observed a significant increase in nuclear area in 40–64% of the population between 0.5 and 2.5 μM of Nut-3a.”
BackgroundInfluentialAging Stem Cells: Transcriptome Meets Epigenome Meets Methylome
Tümpel, S., & Rudolph, K. L. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.04.013 · Cited by 3
“…on human fibroblasts indicated that oncogene-induced Cell Stem Ce senescence leads to a switch in the metabolism of senescent cells exhibiting an increase in energy expenditure, and increases in protein secretion and synthesis were found to be the cause of this metabolic switch (Dörr et al. 2013).”
BackgroundNew Therapeutic Approaches in Treating Cancer
Kasina, A. (2014) · Pharmaceutical Regulatory Affairs Open Access · doi:10.4172/2167-7689.1000128 · Cited by 2
A one-two punch against cancer: combining CDK4 inhibitors with lysosomotropic agents
Ferbeyre, G. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00396-2 · Cited by 2
Current Methodologies to Assess Cellular Senescence in Cancer
Laouris, P., & Muñoz‐Espín, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_2 · Cited by 4
Telomere Length of Cardiomyocytes in Wistar Rat Treated with Doxorubicin: In Vivo Experimental Study
Асанов, М. А., Олеговна, П. А., Sinitskaya, A. V., Khutornaya, M. V., Khryachkova, O. V., & Sinitsky, M. Y. (2025) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-025-06381-3 · Cited by 2
“Senescent cells acquire unique morphological and molecular characteristics and functions [5], sometimes maintaining metabolic activity and viability [6,7].”
Mechanisms of Hematopoietic Stem Cell Ageing and Targets for Hematopoietic Tumour Prevention
Liao, M., & Wang, J. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1117-8_8 · Cited by 2
Senolytics Target Senescent Cells and Improve Aging and Age-Related Diseases
Buffard, T., & Ferbeyre, G. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_4 · Cited by 4
Interconnection Between Cellular Senescence, Regeneration and Ageing in Salamanders
Yu, Q., & Yun, M. H. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_3 · Cited by 2
Cellular senescence in cancers: relationship between bone marrow cancer and cellular senescence
Sarikhani, M., & Firouzamandi, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07101-6 · Cited by 2
Dou, X., Long, Q., Liu, S., Zou, Y., Fu, D., Chen, X., Xu, Q., Wang, C., Ren, X., Zhang, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.21203/rs.3.rs-1966019/v1 · Cited by 2
Payea, M. J., Dar, S. A., Anerillas, C., Martindale, J. L., Belair, C., Munk, R. B., Malla, S., Fan, J., Piao, Y., Yang, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.12.536613 · Cited by 2
Ismaila, M., Dharmaraj, S., Ong, E. B. B., Tye, G. J., & Sasidharan, S. (2025) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-025-00839-5 · Cited by 1
“The accumulation of aged or senescence-affected cells, exacerbated by the ongoing secre - tion of SASP factors along with weakening of the immune system function, causing chronic tissue dysfunction and heightens the vulnerability to diseases of aging (Dörr et al. 2013 ).”
3D models to study therapy-induced senescence: where do we stand now?
Heydari, Z., Malogolovkin, A. S., Smirnova, O., Lyukmanov, D., Filimonova, A., Shpichka, A. I., Vosough, M., & Timashev, P. S. (2025) · Cytotechnology · doi:10.1007/s10616-025-00774-y · Cited by 1
“MSCV encoding oncoprotein H-Ras v12 and MSCV with an oncogenic Ras-to-oestrogen receptor (ER) fusion were used to induced OIS in mouse embryo fibroblasts Tig3 (Dörr et al. 2013).”
Wang, Q., Sun, X., Han, X., Zhang, X., Wang, W., Wang, H., Ren, H., & Gu, L. (2026) · MedComm – Oncology · doi:10.1002/mog2.70054 · Cited by 2
Exploiting cellular senescence in hematologic malignancies
Jiang, P., Yang, G., Li, J., Tian, X., Yang, X., Yang, S., Wei, J., Zhang, X., & Liu, J. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102729 · Cited by 1
Yang, T., Bu, W., Xue, X., Wu, X., Zhou, Y., Chen, Y., Li, Y. S., Zhang, J., Li, P., Shen, F., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104158 · Cited by 3
“In a murine lymphoma model of chemotherapy-induced senescence, for example, blockade of glucose utilization resulted in regression of the tumor mass and improved treatment outcomes [24].”
Filardo, A., Coscarella, I., Bria, J., Vito, A. D., Torre, D. L., Chiarella, E., Giovinazzo, A., Procopio, E., Egiziano, M. T., Lavano, A., et al. (2026) · Cancers · doi:10.3390/cancers18081220 · Cited by 2
Hess, M. S., Al-Shami, K. M., Caballero, C. D., Haenlin, J., Chaves‐Filho, A. B., Schlicker, L., Poeller, P., Vogel, F. C. E., Koltsaki, I., Gedik, D., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01766-x · Cited by 2
Cyclin D1, Metabolism, and the Autophagy-Senescence Balance
Valenzuela, C. A., & Brown, N. E. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_5 · Cited by 2
Therapy Induced Senescence Promote Expression of Death Receptors in Breast Cancer Cells
Eren, M. K., Pilevneli, H., Ak, C., Karlıtepe, A., & Kaygusuz, N. (2021) · Tıpta Yenilikçi Yaklaşımlar Dergisi · doi:10.29329/jiam.2020.299.1 · Cited by 2
Targeting Mitochondria as a Strategy to Inhibit Cellular Senescence
Tan, I. L., & Velarde, M. C. (2021) · Current Molecular Biology Reports · doi:10.1007/s40610-021-00143-6 · Cited by 1
Leveraging the secretory machinery to eliminate senescent cells
(2023) · Nature Aging · doi:10.1038/s43587-023-00500-3 · Cited by 1
CHROMO domain readers: A rainbow of opportunities
Sun, X. S., Shrestha, P., & Mills, A. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823376-4.00009-4 · Cited by 1
Palmer, A. K., & Kirkland, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00012-8 · Cited by 2
Senescence and the Microenvironment
Rai, M. K., Yadav, P., Katailiha, A. S., Singh, A. K., & Yadav, S. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_3 · Cited by 2
Primary Sclerosing Cholangitis
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_5 · Cited by 1
de Pinho, P. G., Carvalho, M. C., & Pinto, J. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-346-7 · Cited by 1
Clinical expression and prognosis of SUV39H1 in diffuse large B-cell lymphomaPreprint
Zhang, Y., Wen, Q., Lei, Y., Ge, J.-J., Kong, X.-S., Wang, W., Wang, Z., Hou, H., Qian, S., Wu, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-418357/v1 · Cited by 1
“TIS-competent lymphomas, which are Suv39H1(+) lymphomas, can increase glucose utilization, produce more ATP and prompt tumor regression[37].”
BackgroundCosta, J. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Role of Autophagy in Cancer Therapy
Ma, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802937-4.00013-2
Using genetics to identify epigenetic and signal transduction targets in cancer
Bhadury, J. (2016) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Residual breast cancer metabolic phenotype after docetaxel treatment
Volpari, T. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
her2 hyper-activation through the production of carboxy-terminal fragments
Angelini, P. D. (2014) · TDX (Tesis Doctorals en Xarxa)
Disruptive chemicals, senescence and immortality
Almagro, F., & Kyoto, S.-K. (2015)
Vascular Aging: from Smooth Muscle Cell Differentiation to Polyploidization
Zhan, S. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28633
Role of Autophagy Inhibition in Tumor Proliferative Arrest
Guo, J. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812146-7.00011-1
The Biologic Interconnections Between Aging and Lymphoma
Falandry, C., Sarkozy, C., & Salles, G. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-44870-1_78-1
Cellular Senescence and Tumor Promotion
Demaria, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-44870-1_79-1
Temporal inhibition of autophagy reveals segmental reversal of aging with increased cancer riskPreprint
Cassidy, L. D., Young, A. R. J., Young, C., Soilleux, E. J., Fielder, E., Weigand, B. M., Brais, R. J., Wiggins, K. A., Clarke, M. C. H., Jurk, D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/528984
Identification of Essential Genes in Hepatocellular Carcinomas using CRISPR Screening
Sheel, A. (2019) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/hv7r-q398
“Work in Clemens Schmitt’s group demonstrated that Adriamycin- or Doxorubicin-induced senescence in a Myc lymphoma model does not induce a strong SASP response (308).”
BackgroundEndometrial Factors Causing Subfertility in CowsPreprint
Matsuyama, S., Nakamura, S., Minabe, S., Sakatani, M., Takenouchi, N., Sasaki, T., Iwata, H., & Kimura, K. (2021) · Research Square · doi:10.21203/rs.3.rs-200187/v1
Pathway Profiling Of Replicative And Induced Senescence
Purcell, M. (2014) · Human Biology
Cellular senescence in the ageing brain: to eliminate or not to eliminate?
Talma, N. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.206630102
Josipović, N. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9136 · Cited by 1
Clinical Expression, Prognosis and Immune Infiltration of SUV39H1 in Diffuse Large B-cell LymphomaPreprint
Zhang, Y., Wen, Q., Lei, Y., Ge, J., Kong, X., Wang, W., Wang, Z., Hou, H., Qian, S., Tang, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-418357/v2
The Biologic Interconnections Between Aging and Lymphoma
Falandry, C., Sarkozy, C., & Salles, G. A. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_78
Casper, R. F. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725384204.793545606
Metadata
- Authors
- Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., Kratzat, S., Purfürst, B., Walenta, S., Mueller-Klieser, W., Gräler, M., Hummel, M., Keller, U., Buck, A. K., Dörken, B., Willmitzer, L., Reimann, M., Kempa, S., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Max Delbrück Center (DE)
- German Cancer Research Center (DE)
- Technical University of Munich (DE)
- Johannes Gutenberg University Mainz (DE)
- Jena University Hospital (DE)
- Universitätsklinikum Würzburg (DE)
- Max Planck Institute of Molecular Plant Physiology (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2013-08-14
- Volume
- 501
- Issue
- 7467
- Pages
- 421-425
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987142903
- Cited by
- 541
- References
- 46
- Citations by year
- 2026: 24 · 2025: 35 · 2024: 42 · 2023: 42 · 2022: 40 · 2021: 55 · 2020: 57 · 2019: 35 · 2018: 45 · 2017: 37 · 2016: 43 · 2015: 41 · 2014: 44 · 2013: 1
- FWCI
- 29.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, therapy-induced senescence, synthetic lethality, metabolic targeting, glucose metabolism, autophagy inhibition, senescence-associated secretory phenotype, proteotoxic stress, endoplasmic reticulum stress, unfolded protein response, SUV39H1, H3K9 methylation, Eμ-Myc lymphoma, chemotherapy-induced senescence
- MeSH terms
- Animals, Autophagy, Disease Models, Animal, Female, Glucose, Male, Mice, Transgenic, Stress, Physiological, Survival Rate, Lymphoma, B-Cell, Cellular Senescence, Apoptosis, Mice, Caspase 3, Caspase 12, Proteolysis, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.